TORONTO, ON — February 11, 2026 — Leads & Copy — DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) will hold a conference call on Wednesday, March 4, 2026, at 8:00 a.m. ET to discuss its fourth quarter and full year 2025 financial results, the company announced. The financial results will be reported on Tuesday, March 3, 2026, after market close.
All interested parties can join the call by dialing 1-888-699-1199 or 416-945-7677 approximately 15 minutes prior to the call. To join without operator assistance, register and enter your phone number at https://emportal.ink/3NBsotM to receive an instant automated callback.
A question-and-answer session will follow management’s prepared remarks, during which the operator will provide instructions for qualified equity analysts to submit questions.
A live webcast with a slide presentation will be available at https://app.webinar.net/Wjkpe3rnQ4q. Connect at least 15 minutes prior to the call to allow time for any required software download. The webcast will be archived on DRI Healthcare’s website following the call date.
DRI Healthcare is a pioneer in global pharmaceutical royalty monetization. Since its founding in 1989, the company has deployed more than $3.0 billion, acquiring more than 75 royalties on over 50 drugs, including Ekterly, Eylea, Keytruda, Orserdu, Remicade, Spinraza, Stelara, Vonjo and Zytiga.
DRI Healthcare’s units are listed and trade on the Toronto Stock Exchange in Canadian dollars under the symbol “DHT.UN” and in U.S. dollars under the symbol “DHT.U”.
Source: DRI Healthcare
